Carcinoma
Survival in Merkel cell carcinoma may improve with Mohs vs. wide local excision
Patients with Merkel cell carcinoma may have better survival outcomes when treated with Mohs micrographic surgery compared with wide local excision, according to a study.
Novel nonsurgical immunotherapy treatment shows promise in basal cell carcinoma
Verrica Pharmaceuticals Inc. has reported lesion clearance data from part one of an ongoing phase 2 study of VP-315 for the treatment of basal cell carcinoma, according to a press release from Verrica’s licensing partner, Lytix Biopharma.
Optical coherence tomography improves basal cell carcinoma detection after topicals
When used in tandem with clinical and dermoscopic examination, optical coherence tomography significantly improved the ability to detect recurrent or residual basal cell carcinomas after topical treatment, according to a study.
Metvix yields positive cosmetic results in basal cell carcinoma treatment
Topical photodynamic therapy and methyl aminolevulinate, marketed as Metvix, displayed effectiveness and good cosmetic outcomes in the treatment of basal cell carcinomas following surgery, according to a study.
Patients with Merkel cell carcinoma see similar survival with wide local excision, Mohs
Wide local excision and Mohs micrographic surgery exhibited no difference in survival outcomes among patients with Merkel cell carcinoma, according to a study.
Lack of consensus among Mohs surgeons diagnosing in situ carcinoma
While most Mohs surgeons agree on diagnostic differentiations between actinic keratosis and squamous cell carcinoma in situ, variability exists in the interpretation of in situ carcinoma on histological frozen sections, according to a study.
Need for consensus in diagnostic practices for actinic keratoses, squamous cell carcinoma
Due to the lack of clarity in literature, widespread implementation of consensus recommendations for actinic keratoses and cutaneous squamous cell carcinoma is needed, according to a study.
Pembrolizumab regimen extends PFS in advanced, recurrent endometrial carcinoma
The addition of pembrolizumab to chemotherapy significantly extended PFS as first-line treatment for advanced or recurrent endometrial carcinoma, according to the agent’s manufacturer.
Robotic liver resection safe, effective for hepatocellular carcinoma
Robotic liver dissection appeared safe and effective compared with open liver resection among patients with hepatocellular carcinoma, according to study results published in JAMA Surgery.